Arlo Health is a technology company.
Arlo Health has raised $4.0M across 1 funding round.
Arlo Health has raised $4.0M in total across 1 funding round.
Arlo Health has raised $4.0M in total across 1 funding round.
Arlo Health's investors include 8VC, MBX Capital.
Arlo Health is a technology-driven health insurer specializing in affordable, innovative health insurance plans for small and medium-sized businesses (SMBs) with 10–150 employees across most U.S. states.[1][2][5] It builds a full-stack platform featuring AI-powered underwriting, seamless API integrations, automated claims processing, and value-based care tools to empower brokers, benefits consultants, and third-party administrators (TPAs) in delivering cost-effective solutions traditionally reserved for large enterprises.[1][2][3] Arlo solves the problem of high premiums and unpredictable costs for SMBs by using machine learning to assess risks accurately, promote preventive care, and enable transparent pricing with features like $0 primary care copays, virtual urgent care, and a 24/7 concierge app.[2][4][5] The company reports mid-eight-figure premiums on the books, underwriting for hundreds of employer groups, signaling strong growth momentum amid rising healthcare costs (up 33% since 2018 for small businesses).[2]
Arlo was founded by Jan-Felix Schneider, who reflects on its beginnings as a mission to transform healthcare by becoming a full-fledged health insurer rather than a point-solution provider, embracing financial risk to drive real change.[3] The idea emerged from recognizing that traditional carriers fail SMBs with opaque practices and inadequate risk management, while Arlo could excel in AI-based underwriting to quantify group risks and model health initiatives.[2][3] Early focus narrowed to owning the underwriting stack and partnering with TPAs and regional health plan architects for community-based plans.[3] A pivotal moment came with a $4M funding round backed by Upfront Ventures, validating its tech edge just as small business frustration with legacy insurers peaked in a $275B market.[2]
Arlo rides the wave of AI in insurtech and value-based care, targeting a $275B small group market where over a third of SMBs use level-funded plans but face 33% cost hikes and poor service from legacy carriers.[2] Timing is ideal amid post-pandemic frustration with high premiums and claims-driven models, as JPMorgan data highlights SMB vulnerabilities.[2] Market forces like rising healthcare inflation favor Arlo's data-driven prevention, which invests savings in employee health attributes for predictable costs.[2][3] It influences the ecosystem by democratizing advanced underwriting for brokers/TPAs, fostering transparent plans, and partnering regionally to scale community-focused care nationwide (excluding select states).[1][5]
Arlo is poised to capture more SMB market share by advancing AI infrastructure for cost prediction, deepening broker ties, and expanding clinical programs amid ongoing healthcare inflation.[3] Trends like AI automation, preventive care mandates, and SMB demand for flexible benefits will accelerate its trajectory, potentially challenging incumbents through multiyear contracts and provider risk-sharing.[2] Its influence may evolve from niche innovator to category leader, redefining accessible insurance as premiums climb—proving that tech can make health plans work for small teams without the big-company barriers.[1][4]
Arlo Health has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Seed in March 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2025 | $4.0M Seed | 8VC, MBX Capital |